Arachidonic Acid

prostaglandin-endoperoxide synthase 1 ; Homo sapiens







98 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33170486 Defining platelet response to acetylsalicylic acid: the relation between inhibition of serum thromboxane B2 and agonist-induced platelet aggregation. 2021 Feb 1
2 33796403 Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells. 2021 Mar 18 1
3 30710016 Interactions of fatty acids, nonsteroidal anti-inflammatory drugs, and coxibs with the catalytic and allosteric subunits of cyclooxygenases-1 and -2. 2019 Feb 1 1
4 30888847 Effects of Aspirin on Growth Factor Release From Freshly Isolated Leukocyte-Rich Platelet-Rich Plasma in Healthy Men: A Prospective Fixed-Sequence Controlled Laboratory Study. 2019 Apr 2
5 30314310 Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature. 2018 Oct 11 2
6 27629384 Combined variants in factor VIII and prostaglandin synthase-1 amplify hemorrhage severity across three generations of descendants. 2016 Nov 2
7 27845343 Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. 2016 Nov 15 2
8 26672987 Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation. 2015 3
9 24207016 Evaluation of laboratory methods routinely used to detect the effect of aspirin against new reference methods. 2014 May 1
10 23384979 Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations. 2013 Mar 1
11 23422285 New direct and indirect methods for the detection of cyclooxygenase 1 acetylation by aspirin; the lack of aspirin resistance among healthy individuals. 2013 Apr 2
12 23473504 Conformational effects on the pro-S hydrogen abstraction reaction in cyclooxygenase-1: an integrated QM/MM and MD study. 2013 Mar 5 2
13 23830213 TXA2 synthesis and COX1-independent platelet reactivity in aspirin-treated patients soon after acute cerebral stroke or transient ischaemic attack. 2013 Aug 1
14 23985963 Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction. 2013 1
15 24482730 Rational Design of Novel Pyridinol-Fused Ring Acetaminophen Analogues. 2013 Aug 8 1
16 21699540 The cyclooxygenase-2 pathway via the PGE₂ EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelination. 2012 May 1
17 22174077 Redox and non-redox mechanism of in vitro cyclooxygenase inhibition by natural quinones. 2012 Mar 1
18 22481026 Long-term CFTR inhibition modulates 15d-prostaglandin J2 in human pulmonary cells. 2012 Jun 1
19 22829846 Rhinosinusitis and aspirin-exacerbated respiratory disease. 2012 2
20 21127289 Protease-activated receptor signaling in platelets activates cytosolic phospholipase A2α differently for cyclooxygenase-1 and 12-lipoxygenase catalysis. 2011 Feb 2
21 21163909 Human prostaglandin H synthase (hPHS)-1 and hPHS-2 in amphetamine analog bioactivation, DNA oxidation, and cytotoxicity. 2011 Mar 1
22 21403766 Cyclooxygenase reaction mechanism of PGHS--evidence for a reversible transition between a pentadienyl radical and a new tyrosyl radical by nitric oxide trapping. 2011 Mar 2
23 21467029 Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer. 2011 May 27 1
24 20194532 Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids. 2010 Jun 1
25 20227521 Decrease in expression or activity of cytosolic phospholipase A2alpha increases cyclooxygenase-1 action: A cross-talk between key enzymes in arachidonic acid pathway in prostate cancer cells. 2010 Jul 1
26 20645164 Expression of cyclooxygenase isoforms in the baculovirus expression system. 2010 1
27 19028575 Kinetic modelling of NSAID action on COX-1: focus on in vitro/in vivo aspects and drug combinations. 2009 Jan 31 1
28 19210337 Cyclooxygenase-2-derived prostaglandin E2 is involved in vascular endothelial growth factor production in interleukin-1alpha-stimulated human periodontal ligament cells. 2009 Jun 1
29 19218248 Cyclooxygenase Allosterism, Fatty Acid-mediated Cross-talk between Monomers of Cyclooxygenase Homodimers. 2009 Apr 10 1
30 19433337 Peroxide-induced radical formation at TYR385 and TYR504 in human PGHS-1. 2009 Jun 1
31 19928795 Characterization of an AM404 analogue, N-(3-hydroxyphenyl)arachidonoylamide, as a substrate and inactivator of prostaglandin endoperoxide synthase. 2009 Dec 29 4
32 19996015 Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization. 2009 Dec 22 1
33 18435972 Platelet inhibition by aspirin 81 and 325 mg/day in men versus women without clinically apparent cardiovascular disease. 2008 May 1 1
34 18536521 COX-2 expression in oral lichen planus. 2008 1
35 18670087 Antiplatelet effect and selective binding to cyclooxygenase by molecular docking analysis of 3-alkylaminopropoxy-9,10-anthraquinone derivatives. 2008 Aug 1
36 18818754 Role of linoleic Acid hydroperoxide preformed by cyclooxygenase-1 or -2 on the regulation of prostaglandin formation from arachidonic Acid by the respective enzyme. 2008 Sep 1
37 17191216 Novel cyclooxygenase-catalyzed bioactive prostaglandin F2alpha from physiology to new principles in inflammation. 2007 Jul 1
38 17209563 Oxyferryl heme and not tyrosyl radical is the likely culprit in prostaglandin H synthase-1 peroxidase inactivation. 2007 Jan 16 2
39 17242290 Letter by Kronish et al regarding article, "Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance". 2007 Jan 23 1
40 17301694 Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1). 2007 Feb 6
41 16551714 Sex differences in platelet reactivity and response to low-dose aspirin therapy. 2006 Mar 22 1
42 16606823 Partnering between monomers of cyclooxygenase-2 homodimers. 2006 Apr 18 1
43 16785341 Residual arachidonic acid-induced platelet activation via an adenosine diphosphate-dependent but cyclooxygenase-1- and cyclooxygenase-2-independent pathway: a 700-patient study of aspirin resistance. 2006 Jun 27 2
44 16952710 Prostacyclin production in tryptase and thrombin stimulated human bladder endothelial cells: effect of pretreatment with phospholipase A2 and cyclooxygenase inhibitors. 2006 Oct 1
45 15869467 Oxygenation by COX-2 (cyclo-oxygenase-2) of 3-HETE (3-hydroxyeicosatetraenoic acid), a fungal mimetic of arachidonic acid, produces a cascade of novel bioactive 3-hydroxyeicosanoids. 2005 Sep 15 1
46 15921208 New immunohistologic findings on the differential role of cyclooxygenase 1 and cyclooxygenase 2 in nasal polyposis. 2005 Mar-Apr 2
47 16433444 [New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences]. 2005 Jun 1
48 15084746 Lactosylceramide recruits PKCalpha/epsilon and phospholipase A2 to stimulate PECAM-1 expression in human monocytes and adhesion to endothelial cells. 2004 Apr 27 1
49 12545150 Genetic variation in cyclooxygenase 1: effects on response to aspirin. 2003 Jan 2
50 12637362 17beta-estradiol decreases vascular tone in cerebral arteries by shifting COX-dependent vasoconstriction to vasodilation. 2003 Jul 1